第一单位：
IDOR -D'Or Institute for Research and Education, Sao Paolo, Brazil; Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
作者：
Antonio,Fagundes [1]
;
David A,Morrow [2]
;
Kazuma,Oyama [3]
;
Remo H M,Furtado [4]
;
Thomas A,Zelniker [5]
;
Minao,Tang [2]
;
Julia F,Kuder [2]
;
Sabina A,Murphy [2]
;
Andrew,Hamer [6]
;
Anthony C,Keech [7]
;
Peter,Sever [8]
;
Robert P,Giugliano [2]
;
Marc S,Sabatine [2]
;
Brian A,Bergmark [9]
作者单位：
IDOR -D'Or Institute for Research and Education, Sao Paolo, Brazil; Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
[1]
Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
[2]
Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
[3]
Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Hospital Israelita Albert Einstein and Instituto do Coração da Faculdade de Medicina da U.S.P., Sao Paulo, Brazil.
[4]
Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardiology, Vienna General Hospital and Medical University of Vienna, Vienna, Austria.
[5]
Cardiol Therapeutics, Oakville, Ontario, Canada.
[6]
National Health and Medical Research Council Clinical Trials Centre, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
[7]
National Heart and Lung Institute, Imperial College London, London, United Kingdom.
[8]
Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: bbergmark@bwh.harvard.edu.
[9]
DOI
10.1016/j.jacc.2022.05.051
PMID
36007987
发布时间
2022-10-07
换一批
